J Postgrad Med Close
 

Figure 2: ISS-adjusted survival estimates based on NPM use. Patients taking 1-2 or 3+ NPMs had significantly lower 90-day survival when compared to patients not taking NPMs (P < 0.01)

Figure 2: ISS-adjusted survival estimates based on NPM use. Patients taking 1-2 or 3+ NPMs had significantly lower 90-day survival when compared to patients not taking NPMs (<i>P</i> < 0.01)